CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 200 target
Drug / intervention
SLT laserdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02955849
NCT02955849Early Ph 1Completed
CompareCT.gov

The China Laser and Surgery Study : A Mixed Methods Study With an Random Control Trial Comparing Outcomes From Selective Laser Trabeculoplasty Versus Surgical Treatment (Trabeculectomy) for Glaucoma in Rural China .

Sun Yat-sen University·interventional·Posted Nov 4, 2016·Updated Mar 19, 2021

In Brief

A Early Phase 1 clinical trial evaluating SLT laser for Glaucoma. Completed, enrolled 200 participants across 1 site.

Detailed Summary

Aims and Objectives (Quantitative) Aim: To compare the effectiveness of selective laser trabeculoplasty with trabeculoplasty in lowering the intraocular pressure in patients with medically uncontrolled open angle glaucoma in rural China, taking into account the impact of patient acceptance of each type of treatment Hypothesis: Mean intraocular pressure after treatment with selective laser trabeculoplasty will be lower than with surgery due to higher acceptance rates among patients randomized to receive this treatment and therefore treatment provided at an earlier stage of disease progression.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGlaucoma
CountriesChina
Collaborators--

Timeline

Early Ph 1CompletedFinished
2017201820192020202120222023202420252026
First PostedNov 4, 2016
Enrollment StartSep 1, 2016
Primary CompletionDec 1, 2019
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 9.7 years ago

Interventions

SLT laserdevice

Patients will be offered initial SLT laser by doctors